These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 18362485

  • 1. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
    Jeong CW, Lim DJ, Son H, Lee SE, Jeong H.
    Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
    [Abstract] [Full Text] [Related]

  • 2. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
    Tuğcu V, Taşçi AI, Fazlioğlu A, Gürbüz G, Ozbek E, Sahin S, Kurtuluş F, Cek M.
    Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
    [Abstract] [Full Text] [Related]

  • 3. Combination regimen in the treatment of chronic prostatitis.
    Chen WM, Yang CR, Ou YC, Ho HC, Su CK, Chiu KY, Cheng CL.
    Arch Androl; 2006 Apr; 52(2):117-21. PubMed ID: 16443588
    [Abstract] [Full Text] [Related]

  • 4. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
    Nickel JC, Downey J, Johnston B, Clark J, Canadian Prostatitis Research Group.
    J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913
    [Abstract] [Full Text] [Related]

  • 5. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M, Peterson J, Fisher AC, Qin Z, Nicholson SC, Kahn JB.
    Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
    [Abstract] [Full Text] [Related]

  • 7. More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.
    Paick JS, Lee SC, Ku JH.
    Prostate Cancer Prostatic Dis; 2006 Jun; 9(3):261-5. PubMed ID: 16683008
    [Abstract] [Full Text] [Related]

  • 8. [Longqingpian combined with levofloxacin highly effective for type IIIA prostatitis].
    Xu H, Shang XJ, Cai X, Teng WH, Huang YF.
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):338-41. PubMed ID: 17491269
    [Abstract] [Full Text] [Related]

  • 9. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS, Parikh A.
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [Abstract] [Full Text] [Related]

  • 10. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI.
    BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
    [Abstract] [Full Text] [Related]

  • 11. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
    [Abstract] [Full Text] [Related]

  • 12. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team.
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [Abstract] [Full Text] [Related]

  • 13. [Combined therapy for the chronic pelvic pain syndrome].
    Xu S, Qi G, Tang P, Li Y.
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):429-30, 433. PubMed ID: 15267206
    [Abstract] [Full Text] [Related]

  • 14. [Corticoid combined with an antibiotic for chronic nonbacterial prostatitis].
    Yang MG, Zhao XK, Wu ZP, Xiao N, Lü C, Hou Y.
    Zhonghua Nan Ke Xue; 2009 Mar; 15(3):237-40. PubMed ID: 19452696
    [Abstract] [Full Text] [Related]

  • 15. [Medication combined with local hyperthermia: a desirable therapy for chronic prostatitis pain symptoms].
    Zhang Y, Sun FL, Zang T.
    Zhonghua Nan Ke Xue; 2008 May; 14(5):451-3. PubMed ID: 18572868
    [Abstract] [Full Text] [Related]

  • 16. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA, Nickel JC, Kattan MW.
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ, Wu SC, Tennenberg AM, Kahn JB.
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [Abstract] [Full Text] [Related]

  • 19. [Yiqigushen capsule combined with levofloxacin highly effective for type III A prostatitis].
    Guo DF, Zhang HZ, Wang HP.
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):88-90. PubMed ID: 18297821
    [Abstract] [Full Text] [Related]

  • 20. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, Talbot MD.
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.